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Abstract
Background: Probiotic bifidobacteria in combination with prebiotic carbohydrates have documented positive
effects on human health regarding gastrointestinal disorders and improved immunity, however the selective routes
of uptake remain unknown for most candidate prebiotics. The differential transcriptomes of Bifidobacterium animalis
subsp. lactis Bl-04, induced by 11 potential prebiotic oligosaccharides were analyzed to identify the genetic loci
involved in the uptake and catabolism of α- and β-linked hexoses, and β-xylosides.
Results: The overall transcriptome was modulated dependent on the type of glycoside (galactosides, glucosides or
xylosides) utilized. Carbohydrate transporters of the major facilitator superfamily (induced by gentiobiose and
β-galacto-oligosaccharides (GOS)) and ATP-binding cassette (ABC) transporters (upregulated by cellobiose, GOS,
isomaltose, maltotriose, melibiose, panose, raffinose, stachyose, xylobiose and β-xylo-oligosaccharides) were
differentially upregulated, together with glycoside hydrolases from families 1, 2, 13, 36, 42, 43 and 77. Sequence
analysis of the identified solute-binding proteins that determine the specificity of ABC transporters revealed
similarities in the breadth and selectivity of prebiotic utilization by bifidobacteria.
Conclusion: This study identified the differential gene expression for utilization of potential prebiotics highlighting
the extensive capabilities of Bifidobacterium lactis Bl-04 to utilize oligosaccharides. Results provide insights into the
ability of this probiotic microbe to utilize indigestible carbohydrates in the human gastrointestinal tract.
Keywords: Bifidobacterium lactis, Transcriptomics, ABC transporter, GPH transporter, Prebiotics, Glycoside hydrolase
Background
Health-promoting microbes, defined as probiotics [1],
have gained increased interest for use in food and dietary
supplement applications to improve health and well being.
Clinical research has shown that bifidobacteria are an im-
portant genus for probiotic interventions through clinical
studies [2,3]. Benefits reported using bifidobacteria include
improvement of bowel functions [4], prevention of necro-
tizing enterocolitis in infants [5], treatment of Crohn’s
disease [6] and modulation of immune functions in the
elderly [7]. Understanding the mechanisms of action
underlying the probiotic attribute of bifidobacteria on the
molecular level has been restricted to functional extrapo-
lation from genome sequencing [8]. Interestingly, from the
53 Bifidobacterium genomes that have been deposited
publicly to date, comparative analysis has revealed the
genetic diversity of bifidobacteria [9], leading to identifica-
tion of genetic loci for colon adaptation by host mucin
degradation in B. bifidum [10], foraging of dietary carbo-
hydrates in e.g. B. longum [11] or the important feature of
human milk utilization [12] enabling colonization of the
infant GIT [11,13,14] .
Enhancement of beneficial microbes within the gastro-
intestinal tract (GIT) can be achieved by providing select-
ively utilizable carbohydrates [15], defined as prebiotics
[16]. Prebiotics are dietary carbohydrates, resistant to the
host digestive system and main commensal microbiota
residing in the colon. To date, only a few carbohydrates
have been documented as prebiotics, namely β-galacto-
oligosaccharides (GOS), lactulose, fructo-oligosaccharides
and inulin [17]. Several candidate prebiotics have been
proposed, but there is a need for additional studies that
document their selective utilization by beneficial microbes
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within the human GIT [18,19]. The diversity of prebiotics
with respect to size, composition and glycosidic linkages
require a multitude of transporters and hydrolytic en-
zymes, some of which are predicted to occur widely within
bifidobacteria, based mostly on in silico analysis [20,21].
Bifidobacterium animalis subsp. lactis has been
reported to exert positive effects as a probiotic microbe in
clinical studies [22,23], or when supplemented as a
synbiotic in combination with prebiotics [24]. The
annotated genome sequence of B. lactis Bl-04 revealed
putative prebiotic transport and catabolic pathways,
suggesting the bacterium to be highly adapted to the GIT
and capable of utilization of dietary-derived complex oligo-
saccharides [25]. In the present study, we used differential
transcriptomics to identify genetic loci encoding uptake
and hydrolytic pathways of potential prebiotics manifested
by 11 structurally diverse galactosides, glucosides and
xylosides within B. lactis Bl-04. This work validated and
expanded the tentative in silico predictions of oligosaccha-
ride transporters and specificities of glycoside hydrolases.
Furthermore the perspective of the study enables the
combination of transcriptomics and genome mining to
serve as a platform for future functional work within
prebiotic utilization by bifidobacteria.
Results
Oligosaccharide induced global transcriptome profile of
B. lactis BL-04
Global gene expression profiles were obtained for B. lactis
Bl-04, exponentially growing on 11 potential prebiotic
oligosaccharides and glucose (Table 1), representing α-
galactosides (melibiose, raffinose and stachyose), β-
galactosides (GOS), α-glucosides (isomaltose, maltotriose
and panose), β-glucosides (cellobiose and gentiobiose) and
β-xylosides (xylobiose and xylo-oligosaccharides (XOS)).
Growth of B. lactis Bl-04 on various mono, di and oligo-
saccharides were previously published [26]. The gene ex-
pression levels were quantified by whole genome DNA
microarrays showing an overall comparable gene expres-
sion profiles across all 12 carbohydrate treatments and
with high technical reproducibility (Figure 1). Only a sub-
set of genes were upregulated differentially in response to
each oligosaccharide, although a slight deviation of the
GOS and xylobiose samples was observed. The 10 % of
the highest constitutively expressed genes for all carbohy-
drate treatments (163 genes) were assigned Clusters of
Orthologous Groups (COG) categories [27] and empha-
sized main cellular functions of growth and energy turn-
over (Figure 1). Notably, of the highly expressed single
genes (listed by B. lactis Bl-04 locus tag numbers), several
highlight molecular functions related to probiotic mecha-
nisms in B. lactis putatively involved in fibronectin adhe-
sion (Balac_1484–1485), host plasminogen interactions
(Balac_1017 and Balac_1557), phage immunity [28]
(Balac_1305), bile salt hydrolysis (Balac_0863) and perox-
ide reduction (Balac_0865). In addition, part of an oligo-
saccharide ATP-binding cassette (ABC) transporter
encoding a solute-binding protein (SBP) (Balac_1565), and
an ATP-binding protein associated with oligosaccharide
uptake by ABC transporters (Balac_1610) were both
found, linking catabolic adaptation to the primary physio-
logical functions of B. lactis Bl-04. These findings correlate
with previously proposed molecular functions related to
probiotic mechanisms in B. lactis [29].
Functional grouping of global gene expression was
observed based on the type of glycoside utilized
Table 1 Carbohydrates, used for DNA microarray studies, listed with glycoside structure and type, supplier and purity
Carbohydrate Structure1 Glycoside type DP2 Manufacturer or supplier Purity (as given by
Manufacturer or supplier)
Glucose Glcp glucoside 1 Sigma > 99%
GOS [β-D-Galp-(1–4)]n-D-Glcp galactoside 2–6 Dupont > 94% DP≥ 2
Melibiose α-D-Galp-(1–6)-D-Glcp galactoside 2 Sigma > 98%
Raffinose α-D-Galp-(1–6)-D-Glcp-(α1,β2)-D-Fruf galactoside 3 Sigma > 99%
Stachyose [α-D-Galp-(1–6)]2-D-Glcp-(α1,β2)-D-Fruf galactoside 4 Sigma > 98%
Isomaltose α-D-Glcp-(1–6)-D-Glcp glucoside 2 Sigma > 98%
Panose α-D-Glcp(1–6)-α-D-Glcp-(1–4)-D-Glcp glucoside 3 Sigma > 98%
Maltotriose α-D-Glcp-(1–4)-α-D-Glcp-(1–4)-D-Glcp glucoside 3 Dupont > 95%
Cellobiose β-D-Glcp-(1–4)-D-Glcp glucoside 2 Fluka AG > 99%
Gentiobiose β-D-Glcp-(1–6)-D-Glcp glucoside 2 Sigma > 98%
Xylobiose β-D-xylp-(1–4)-D-xylp xyloside 2 Dupont > 95%
XOS [β-D-xylp-(1–4)]m-D-xylp xyloside 2–7 Shandong Longlive Bio-
technology Co., Ltd, (China)
> 90%3
1n = 1–5 as previously described (70), m =1–6 as stated by manufacturer.
2Degree of polymerization.
3The XOS composition and purity was previously determined [60].
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(galactosides, glucosides or xylosides) from principal
component analysis (Figure 2). A clear differentiation of
the expressed global transcriptome was observed based
on the type of glycoside utilized, indicating that prebi-
otics can affect the global transcriptome, and therefore
physiological functions in B. lactis Bl-04. Furthermore,
specific genetic loci were significantly differentially regu-
lated by specific carbohydrates, which indicates their
potential involvement in the uptake and catabolism of
the respective glycosides (Figure 1).
Differentially upregulated genes conferring potential
prebiotic utilization
Analysis of the differential upregulation of specific genes
mediating potential prebiotic utilization was conducted
by one-way analysis of variance (ANOVA) and visualized
by volcano plots (Figure 3) to identify statistically signifi-
cant genes (cut off: p-value < 10-8.04) upregulated by each
carbohydrate in the whole genome DNA microarray. An
average of 56 genes were more than 2-fold differentially
upregulated and above the statistical threshold for each
pairwise comparison. Analysis revealed how subsets of
genes involved with oligosaccharide metabolism were
consistently differentially expressed throughout the
ANOVA (Table 2, and Figure 4 for real time
quantitative-PCR validation of selected genes). This led
to the reconstruction of six putative gene clusters based
on the differential upregulation of specific genes to spe-
cific oligosaccharide treatments. Gene clusters encoding
a transporter and glycoside hydrolase(s) were linked to
the uptake and degradation of substrates that varied in
the degree of polymerization, glycosidic linkage or
monosaccharide composition.
Moreover, the relative induction of gene clusters
involved in carbohydrate uptake and catabolism
(Figure 5) strongly supports the identification of the
Figure 1 Two-way clustering of the global gene expression profiles and COG distribution of constitutively expressed genes. Gene
expression intensities are represented by red coloring: up-regulation, blue coloring: down-regulation. Technical replicates for each carbohydrate
are numbered and showed overall high reproducibility. The highest expressed decile (163 genes) of the global transcriptome across all
carbohydrates conditions was assigned COG categories (assigned both as numbers and percentages), highlighting essential metabolic pathways
of B. lactis Bl-04.
Figure 2 Principal component analysis of the global
transcriptome for B. lactis Bl-04 cultivated with prebiotics
showing differentiation of the global gene expression profiles
depending on the glycoside type of carbohydrates utilized
(pca2 = 22.2%). Galactosides in red (GOS, melibiose, raffinose,
stachyose), glucosides in green (cellobiose, gentiobiose, glucose,
maltotriose, isomaltose, panose) and xylosides in blue
(XOS, xylobiose).
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Figure 3 Representative volcano plots of pairwise comparisons of the oligosaccharide-induced differential global transcriptome in
B. lactis Bl-04. All genes are shown by solid grey circles, and putative carbohydrate-active protein encoding genes that were significantly
up-regulated are highlighted with solid circles and color-coded by gene cluster and as listed in Table 2: cluster A (blue), cluster B (orange),
cluster C (purple), cluster D (light blue), cluster E (green) and cluster F (red).
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differential specificities of upregulated proteins involved
with utilization of the various oligosaccharides.
Gene cluster analysis and functional assignment
Analysis of differentially up-regulated loci enabled the
identification of six gene clusters conferring the uptake
and hydrolysis of the oligosaccharides used in the study
(Figure 6A–F). Common to all the identified loci is that
they encoded a transport system, a transcriptional regula-
tor and one or more glycoside hydrolases (GHs) as pre-
dicted from the glycoside hydrolase family annotation in
the CAZy database [30] (Figure 3). Four ATP-binding
Table 2 Statistically significant upregulated genes involved in carbohydrate uptake and catabolism
ORF Gene annotation Inducing CHO
type
Volcano plot
(Figure 3)
Highest
inducing CHO
Gene cluster
(Figure 5)
Fold
upregulated
-log10
(P-value)
Balac_0053 β-galactosidase, GH42 Glucoside C gentiobiose A 6.5 13.8
Balac_0054 MFS permease Glucoside C gentiobiose A 4.8 11.8
Balac_0475 MFS permease Galactoside A GOS B 21.8 19.9
Balac_0476 β-galactosidase, GH2 Galactoside A GOS B 36.9 17.9
Balac_0484 β-galactosidase, GH42 Galactoside A GOS C 11.4 17.2
Balac_0485 ABC transporter, permease
component
Galactoside A GOS C 8.4 16.2
Balac_0486 ABC transporter, permease
component
Galactoside A GOS C 5.7 12.9
Balac_0511 Xylose isomerase xyloside A,C XOS D 13.8 15.1
Balac_0512 α-L-arabinofuranosidase, GH43 xyloside A,C XOS D 6.8 13.6
Balac_0513 Transcriptional regulator (lacI type) xyloside A,C Xylobiose D 3.0 10.1
Balac_0514 ABC transporter, oligosaccharide-
binding protein
xyloside A,C XOS D 9.0 16.0
Balac_0515 ABC transporter, permease
component
xyloside A,C XOS D 16.8 16.5
Balac_0516 ABC transporter, permease
component
xyloside A,C XOS D 18.3 17.5
Balac_0517 β-xylosidase, GH43 xyloside A,C XOS D 17.9 16.1
Balac_0518 Putative carbohydrate esterase xyloside A,C XOS D 14.2 11.3
Balac_0519 Esterase xyloside A,C XOS D 6.9 15.1
Balac_0520 α-L-arabinofuranosidase, GH43 xyloside A,C XOS D 10.2 15.2
Balac_0521 Xylulose kinase xyloside A,C Xylobiose D 18.2 19.0
Balac_1567 4-α-glucanotransferase glucoside B,D Maltriose E 9.7 14.5
Balac_1569 ABC transporter, permease
component
glucoside B,D Cellobiose E 5.2 13.7
Balac_1570 ABC transporter, permease
component
glucoside B,D Cellobiose E 3.7 15.1
Balac_1571 Transcriptional regulator (lacI type) glucoside B,D Cellobiose E 3.7 13.1
Balac_1572 ABC transporter, oligosaccharide-
binding protein
glucoside B,D Cellobiose E 3.2 12.1
Balac_1593 oligo-1,6-α-glucosidase, GH13 Galactoside,
Glucoside
B,D,E Isomaltose F 4.5 14.0
Balac_1597 ABC transporter, permease
component
Galactoside,
Glucoside
B,D,E Raffinose F 14.1 13.9
Balac_1598 ABC transporter, permease
component
Galactoside,
Glucoside
B,D,E Isomaltose F 20.1 18.6
Balac_1599 ABC transporter, oligosaccharide-
binding protein
Galactoside,
Glucoside
B,D,E Isomaltose F 17.8 16.7
Balac_1601 α-galactosidase, GH36 Galactoside,
Glucoside
B,D,E Raffinose F 8.1 16.4
The genes are listed by ascending locus tag numbers with the principle type of glycoside. Only the oligosaccharide that elicited the highest significance level
(−log10(P-value)) is listed for genes that are upregulated by more than one oligosaccharide.
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cassette (ABC) systems and two major facilitator super-
family (MFS) transporters, including one putative
glycoside-pentoside-hexuronide (GPH) system were iden-
tified [31], supporting the differential expression of gene
clusters being induced by multiple oligosaccharides
(Figure 3).
Gene cluster A, differentially up-regulated by gentio
biose, encoded an MFS transporter (Balac_0054), with
only 25% amino acid sequence identity to a sucrose per-
mease from Arabidopsis thaliana (uniprot: Q9FG00),
and an intracellular (as predicted by SignalP 4.0 [32])
putative β-galactosidase of GH42 (Balac_0053), adjacent
to a GH30 subfamily 1 (GH30_1) putative β-glucosidase
(Balac_0052) [33] not identified from the ANOVA.
Interestingly, GH42 enzymes are only reported to be
active on β-galactoside linkages [34], whereas GH30_1
enzymes harbor several specificities including endo-
β-[1,4]-glucosidases rendering the GH30_1 a likely
candidate for gentiobiose hydrolysis. Interestingly, co-
occurrence of the GH42 and the GH30_1 genes is also
observed in other bifidobacteria e.g. B. adolescentis
ATCC 15703 and B. dentium Bd1. The rationale for the
co-occurrence of these two GH genes is currently un-
clear, but the data identifies a novel route for gentiobiose
uptake via the MFS transporter and hydrolysis by the
putative GH30_1 family β-[1,4]-glucosidase.
The GOS substrate upregulated the expression of two
loci: an MFS transporter (Balac_0475) homologous to
the lactose transporter from B. longum NCC2705 [35],
and a typical GH2 β-galactosidase (Balac_0476, cluster
B) and cluster C (Balac_0483–0486) encoding the
heterodimeric permease and the solute binding protein
of an ABC transport system along with a GH42 putative
β-galactosidase. The upregulation of two loci with a
similar architecture was also reported in B. breve [36].
Xylobiose and XOS induced locus D encoding an ABC
transporter, a putative GH43 β-xylosidase (Balac_0517)
and two putative GH43 arabinofuranosidases (Balac_05
12 and Balac_0520) identified based on homology to
characterized bifidobacterial enzymes [37,38]. This
suggests that the gene cluster mediates the transport
and hydrolysis of both undecorated and arabinosyl-
decorated XOS. The gene cluster also encodes a xylose
isomerase and a xylulose kinase necessary to convert xy-
lose to xylulose-5P, phosphate for entry into the bifid-
shunt pathway [39]. The removal of acetyl sidechains
that typically occur at the C2 or C3 of mainchain xyloxyl
residues and feruloyl esters at the C5 or C2 of arabinosyl
decorations in arabinoxylan is a prerequisite for the
utilization of decorated arabinoxylo-oligosaccharides
[40]. Notably, two putative carbohydrate esterases
(Balac_0518 and Balac_0519) were upregulated
highlighting the ability of the B. animlais subsp. lactis to
remove acetyl or feruloyl sidechains from imported
arabinoxylan fragments.
The organization and type of genes in cluster E
showed resemblance to maltose operons from B. longum
NCC2705 [35]. In the current study, however, the gene
Figure 4 Heat map representation of RT-qPCR validation of
microarray gene expression values. The mRNA transcript level
were quantified for each of the five genes in each of the 12
carbohydrate conditions and color-coded as the relative fold
upregulation of each gene: Blue [1–2], light blue [5–9], red [9–17]
and strong red [>16].
Figure 5 Two-way clustering of the expression profile for genes identified to be differentially upregulated by ANOVA. The coloring of
each ORF corresponds to the gene cluster of Figure 2 and Table 2.
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cluster was also upregulated by the trisaccharides
panose, maltotriose and remarkably the β-linked
disaccharide cellobiose. The gene landscape of this
maltooligosaccharide gene cluster differed in the types
of glycoside hydrolases encoded in the comparison to
counterparts reported in other Gram positive bacteria
[41–43] suggesting divergence in α-glucan metabolism.
An ABC transporter was identified in cluster F and
was induced by the raffinose family oligosaccharides
(RFO) melibiose, raffinose and stachyose representing
α-1,6 linked galactosides, along with the α-1,6 linked
glucosides isomaltose and panose. The GH36 subfamily
1 (GH36_1, Balac_1601) α-galactosidase [44] confers the
hydrolysis of the α-1,6 linked galactosides, while the
GH13 oligo-α-1,6-glucosidase (Balac_1593) catalyzes the
hydrolysis of α-1,6 linked glucosides [45]. B. lactis Bl-04
encoded a total of three GH36, yet the remaining two
(Balac_1537 and Balac_1596) were not differentially
expressed. Further analysis of the global transcriptome
(Figure 1) showed low basal expression of Balac_1537 in
all conditions suggesting that the gene product plays a
continuous metabolic role in cell function, while
Balac_1596, assigned to GH36_2 (homologous to plant
raffinose synthases [44]) was not expressed under these
conditions.
In summary, all proposed pathways deduced from the
identified gene clusters are shown in Figure 7, where
potential prebiotic oligosaccharides are internalized and
hydrolyzed into products that can be metabolized by the
bifid shunt pathway [39]. Consistently, the majority of
the bifid shunt genes were found to be highly expressed
in all conditions as marked in Figure 7. Notably, a single
putative phosphoketolase gene is encoded in B. lactis
Bl-04, suggesting that this gene product could phosp-
horolyse both fructose-6P and xylulose-5P as the initial
step of the bifid shunt, as previously described within
B. lactis [46].
Differentiation of transporter functionalities by
transmembrane topology and sequence diversity
To differentiate the functionality of ABC and MFS trans-
porters, the putative α-helical topology of the membrane
spanning domains of all predicted oligosaccharide trans-
porters in B. lactis Bl-04 was mapped (Table 3). Notably,
the gentiobiose-specific MFS transporter (Balac_0054)
possesses 11 predicted transmembrane helices, indicat-
ing structural-functional divergence from previously
identified homologous MFS permeases displaying mainly
12 transmembrane helix topology [47]. Furthermore,
one permease protein (Balac_1570) constituting part of
the maltotriose upregulated ABC transporter was found
to be N-terminally truncated and lacking two helices im-
plicated in heterodimer formation in the permease do-
main of the maltose ABC transporter from Escherichia
coli [48]. Comparison to an additional putative B. lactis
Bl-04 maltose transporter (Balac_1563–1565) and the
experimentally verified maltose ABC transporters from
Lactobacillus casei [42] and Streptococcus pneumoniae
[49] showed that all harbored the additional two
α-helical domain, suggesting the divergence of the
maltotriose ABC transporter (Balac_1569, 1570 and
1572) from known maltose ABC transporters.
Four of the five in silico annotated ABC transporters
[25] were found to be differentially upregulated, while
the remaining putative maltose ABC transporter
discussed above (Balac_1563–1565) was found to be
constitutively expressed to a comparable level. The
transcriptomics data enabled the identification of novel
Figure 6 Organization of differentially expressed gene clusters encoding proteins predicted to be involved with prebiotic utilization.
Genes are listed with locus tag numbers and gene functions are colored as: glycoside hydrolases in red, ABC transporter SBPs- and permeases
(perm) in green, MFS transporters in blue, transcriptional regulators (reg) in light grey and hypothetical proteins (hypo), carbohydrate esterases
(ester1 and ester2), xylose isomerase (xyl.iso) and xylulose kinase (xul.kin) all in dark gray. A short putative nonfunctional ORF is highlighted by a
black triangle.
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specificities and multiple ligand recognition by the SBPs,
recognized as specificity determinants for ABC trans-
porters [50]. This is in agreement with the binding plas-
ticity proposed for ABC-mediated transport [50]. To
elaborate on these findings, the phylogenetics of the
SBPs were compared to known protein orthologs
(Supplemental Table) identified from bifidobacteria and
pathogenic GIT-associated bacteria (Figure 8), hence
displaying the functional and taxonomical distribution of
oligosaccharide SBPs.
Discussion
Bifidobacteria have been shown to exert a positive influ-
ence on the human gut [51] and may selectively utilize
oligosaccharides of plant and milk-derived prebiotics
[52]. Despite significant advances in bacterial genomics,
understanding of carbohydrate uptake and catabolism
mechanisms remains elusive, mainly because of poor
overall annotation of oligosaccharide transporters where
recent advances in uptake of human derived glycans [53]
combined with the present study will enable improved
functional overview of the Bifidobacterium genus with
respect to carbohydrate utilization as an important fac-
tor for competitive GIT colonization and pathogen
inhibition.
The global transcriptome of B. lactis Bl-04
The catabolic adaptation potential of B. lactis Bl-04
became apparent from the global comparison of oligo-
saccharide induced gene expression by principal compo-
nent analysis (Figure 2). The altered global gene
expression by the type of glycoside metabolized (galacto-
side, glucoside or xyloside) was not influenced by the
differentially expressed gene clusters involved in the up-
take and catabolism of oligosaccharides. It is likely that
global gene expression, induced by carbohydrate source,
involves modulation of the metabolic equilibrium within
the bacterium. This was observed in B. longum for
glycoside-induced changes in exopolysaccharide produc-
tion [54] and the inhibition of enteropathogens by acid-
ification when metabolizing fructose rather than glucose
[55]. These findings underscore the effects associated
with the catabolism of glycoside type on the overall
behavior and potentially probiotic functionality of
bifidobacteria in the GIT. Because of the importance for
selective utilization of oligosaccharides, we hypothesize a
vital role of ABC transporters for prebiotic uptake. Inter-
estingly, a sole oligosaccharide ABC transporter-specific
ATP-binding protein was identified in the genome
and found to be constitutively highly expressed, consist-
ent with a single ATP-binding protein energizing mul-
tiple oligosaccharide ABC transporters as previously
Figure 7 Proposed pathways for oligosaccharide uptake and catabolism into monosaccharides for entry into the bifid shunt.
Transporters are colored as in Figure 6 and all genes are given by their locus tag. The schematic pathways for glucose (entering as glucose-1P),
galactose, fructose (entering as fructose-6P) and xylose are shown with the main steps of the bifid shunt. All constitutive highly expressed genes
(Figure 1) are denoted with an asterisk (*).
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described [56]. Likewise, various genes encoding proteins
linked to proposed probiotic mechanisms of action, such
as adhesion (Balac_1484–1485), phage immunity
(Balac_1305) and bile salt hydrolysis (Balac_0863) were
found to be highly expressed, supporting the clinically
proven probiotic nature of B. lactis Bl-04 and reflecting
the adaptation to the conditions of the GIT.
Analysis of the differentially expressed genes of
B. lactis Bl-04 involved in prebiotic utilization revealed
upregulation of explicit gene clusters, as was also ob-
served from previous studies of oligosaccharide
utilization in probiotic bacteria [35,57]. The uptake of
oligosaccharides was facilitated by ABC and MFS types
of oligosaccharide transporters, by the lack of phosphoe-
nolpyruvate-dependent phosphotransferase systems in
the B. lactis Bl-04 genome [25], all associated with glyco-
side hydrolases.
Oligosaccharide ABC transporters
The phylogenetic analysis of homologs of identified ABC
transporters allowed the assignment of the SBPs identi-
fied in the current study into functional clusters harbor-
ing experimentally identified counterparts. Within each
functional cluster, protein orthologs segregated based on
taxonomic distance. Evolutionary adaptation was evident
from this analysis as the milk disaccharide lacto-N-biose
specificity defined by cluster LacN is almost exclusively
found within bifidobacteria, while XOS SBP orthologs
were dominated by soil bacteria and few GIT associated
bacteria with the majority originating from Actinobac-
teria. This suggests that XOS utilization by bifidobacteria
shares a metabolic niche within the GIT with xylan util-
izing commensal bacteria [58].
The phylogenetic analysis indicates convergent evolu-
tion of a subset of maltose ABC transporter, based on
the upregulated maltotriose ABC transporter (Balac_15
69, 1570 and 1572). The diversity of canonical maltose
SBP orthologs was illustrated by their segregation into
four sub-clusters (clusters Mal1–Mal4), where a taxo-
nomical sub-clustering was observed. A distant
sub-cluster (Mal5) was defined by the maltotriose
upregulated binding protein (Balac_1572). Notably, the
corresponding permease domain of this ABC transporter
was distinguished from identified maltose specific coun-
terparts by the lack of two N-terminal α-helices
(Balac_1570, Table 3), supporting the proposed conver-
gent nature of this type of maltose transporter, which
seems to share topological features with the raffinose
and XOS type binding proteins (Figure 8).
Novel specificities of glycoside hydrolases for GIT
adaptation
Identification of single gene being differentially upregu-
lated by specific oligosaccharides revealed novel enzyme
substrate specificities as compared to the initial in silico
annotation of the hydrolytic capabilities of B. lactic
Bl-04 [25]. Interestingly, the observation of a GH42
β-galactosidase being induced by the β-1,6-glucoside
gentiobiose was intriguing as only β-galactosidases have
been reported in this family. Thus, the GH30_1 putative
β-glucosidase is the more likely candidate for
gentiobiose hydrolysis. Nonetheless, the transcriptomics
data suggests that gentiobiose is specifically transported
Table 3 Prediction of α-helical topology within oligosaccharide transporters identified in B. lactis Bl-04
ORF Predicted substrates Class Predicted TMH1 Sequence length (aa)
0054 Gentiobiose MFS 11 384
0139 Sucrose (putative) MFS 12 537
0475 GOS GPH homolog of MFS 12 505
1240 FOS (putative) MFS 12 441
1588 arabinofuranosides (putative) GPH homolog of MFS 12 481
0485 GOS ABC 6 326
0486 GOS ABC 6 322
0515 XOS ABC 6 352
0516 XOS ABC 6 289
1563 Maltose (putative) ABC 6 322
1564 Maltose (putative) ABC 8 457
1569 Maltotriose ABC 6 278
1570 Maltotriose ABC 6 284
1597 RFO + IMO ABC 6 301
1598 RFO + IMO ABC 6 330
1Transmembrane α-helices (TMH) predicted using the Phobius tool [71].
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by the MFS permease, thus defining a novel specificity
for this MFS transporter. It remains to be investigated if
additional substrates are taken up by the MFS permease
including possible substrates for the upregulated GH42,
which exhibits modest sequence identity (≈30%) to char-
acterized GH42 enzymes.
No putative glycoside hydrolase was differentially
up-regulated on cellobiose. However, transcriptional
mining of B. lactis Bl-04 identified a constitutively
expressed GH1 β-glucosidase (Balac_0151). The
β-glucosidase displayed 51% amino acid identity to
the GH1 β-glucosidase from B. brevis UCC2003
shown to be active on cellobiose and cellodextrin (β-
1,4-glucooligosaccharides) initially trans-ported by an
ABC transporter [59], supporting the suggested func-
tion of Balac_0151. Furthermore, the only trans-
porter differentially up-regulated on cellobiose was
the above ABC transporter (Balac_1572) which was
also up-regulated by maltotriose (Figure 5). This
indicates a potentially dual specificity of the trans-
porter likely to have evolved from multiple sugar
metabolism-types of oligosaccharide ABC trans-
porters (Figure 8).
The uptake and catabolism of XOS within bifidobacteria
was recently proposed [37,60]. Comparative genomic of
genes involved with XOS utilization within bifidobacteria
(Figure 9) reflected a core gene structure of the XOS ABC
transporter with a GH43 β-1,4-xylosidase (Balac_0517),
while the occurrence of arabinofuranosidases, xylanases of
GH8 and GH120 and carbohydrate esterases suggested
more species and strain specific adaptation to utilize spe-
cific types of XOS e.g. arabinosyl decorated fragments. The
multiplicity of GH43 arabinofuranosidases reflects the com-
plexity of arabinosyl decorations that occurs naturally in
arabinoxylan and its degradation products. Two putative
oligosaccharide esterases, distantly related to previously
identified xylan acetyl esterases [61] and conserved among
bifidobacteria, were upregulated by XOS and xylobiose in
B. lactis Bl-04. This implicates these putative esterases in
de-esterification of xylan fragments transported into
bifidobacteria. Taken together, this suggests an exquisite
metabolic versatility in the uptake and utilization of xlyan
degradation fragments that occur naturally with a diversity
of arabinosyl and esterified side chain decorations.
The ABC transporter mediated uptake of GOS
coupled with co-induction of a GH42 showed homology
to a B. longum NCC2705 gene cluster upregulated by
lactose [35]. Interestingly this gene cluster diverges from
those identified for human milk oligosaccharide uptake
[62] both by the similarity of the associated SBP
(Figure 8, LacN versus GOS) and the GH encoded in the
gene clusters (GH42 versus GH112). Therefore, B. lactis
Bl-04 has evolved a broad oligosaccharide utilization
profile for potential prebiotics and dietary fibers.
Conclusion
In conclusion, the overall global gene expression of B.
lactis Bl-04 was dependent of the type of glycoside uti-
lized (galactosides, glucosides or xylosides) potentially
linking the prebiotic catabolism of the bacteria to the
overall behavior in the GIT. From the transcriptional
analyses, we identified the genetic loci encoding MFS
and ABC transporters concurrently with glycoside
hydrolases for utilization of potential prebiotic oligosac-
charides of α- and β-linkages and varying glycoside com-
position. This highlights the metabolic versatility of B.
lactis Bl-04 and offers a means of enhancing probiotic
effects by dietary supplementation with novel prebiotics.
Furthermore, this study provides molecular level support
for utilization of potential prebiotics, some of which are
already known to be bifidogenic, and paves the way for
expanding synbiotic formulations targeting specific
groups of probiotic bacteria.
Figure 8 Functional comparison of the identified
oligosaccharide SBPs of ABC transporters in B. lactis Bl-04. The
phylogenetic tree was rooted by a characterized fructose-binding
protein [69] as a functional and structural outlier group of
oligosaccharide-binding proteins [50]. Sub-clusters were defined by
bootstrap values in percentages and the characterized SBP(s)
identified within each sub-cluster, where the number of sequences
are listed in brackets. The tree was colored by substrate specificity
(maltose-binding proteins (green), cellodextrins (orange), GOS and
lacto-N-biose (blue), XOS (light blue) and raffinose family
oligosaccharides (red)) and sub-clusters were denoted by numbers
as given in Table 4. The raffinose family oligosaccharide cluster was
seemingly sub-clustering into two parts but with the current data
could not be supported by boot-strap analysis.
Andersen et al. BMC Genomics 2013, 14:312 Page 10 of 14
http://www.biomedcentral.com/1471-2164/14/312
Methods
Culture preparation
B. animalis subsp. lactis Bl-04 (ATCC SD5219) was ori-
ginally isolated from a human fecal sample [25]. Cultures
prepared for transcriptional analysis were propagated in
0.22 μm filtered LABSEM media [63] pretreated by the
Hungate method for oxygen removal [64]. The media
was supplemented with 1% (w/v) of the 12 tested carbo-
hydrates (Table 1) and each culture was transferred for
five passages, under anaerobic conditions, on each
carbohydrate before being harvested in the early loga-
rithmic growth phase (OD600 = 0.3–0.5) by centrifuga-
tion at 4°C (3,000 g for 15 min) and flash freezing of the
cell pellet for storage.
RNA isolation and microarray hybridization
Cells were mechanically disrupted by beadbeating and
total RNA was isolated using Trizol-chloroform extraction
(Invitrogen, Carlsbad, CA). Genomic DNA was removed
with Turbo DNAse (Ambion, Austin, TX), followed by
RNA purification using a RNeasy Mini Kit (Qiagen Inc.,
Valencia, CA) [65].
Reverse transcription of total RNA, fragmentation and
3’ biotin labeling of cDNA was done using 10 μg of total
RNA in duplicates for each of the 12 conditions and
microarray hybridizations were performed using the
Affymetrix GeneChip® system (Affymetrix, Santa Clara,
CA). Total RNA was reverse transcribed using random
primers and SuperScript II Reverse Transcriptase
(Invitrogen, Carlsbad, California) and cDNA was purified
using MinElute PCR Purification kit (QIAGEN, Inc.,
Valencia, CA) with a final elution volume of 12 μl. Subse-
quently, cDNA fragmentation into 50–100 bp was
performed using DNase I (GE Healthcare, Waukesha, WI)
and cDNA fragments were biotin-labeled using GeneChip
DNA labeling reagent (Affymetrix) and terminal
deoxynucleotidyl transferase (Promega, Madison, WI).
Labeled cDNA fragments were hybridized at Utah
State University using Affymetrix custom-made chips.
All extracted data was imported into SAS JMP Genom-
ics (SAS Institute Inc, Cary, NC) before being quantile
normalized and modeled using a one-way ANOVA for
identification of differentially upregulated genes using a
threshold value of α = 0.005 and Bonferroni correction.
The full genome transcriptome (98.1% of the total
ORF) for each of the 12 growth conditions was used
for the one-way ANOVA analysis. The pairwise ana-
lysis was done by comparing each single condition to
the other 11 for a total of 66 pairwise conditions. To
each of these 66 comparisons, the ANOVA identified
a number of genes that were significantly upregulated,
for further in silico validation by real-time quantative
PCR of selected genes. The identified upregulated
genes from the ANOVA were then annotated for po-
tential involvement in carbohydrate utilization.
Real-time quantitative PCR (RT-qPCR) validation of
microarray
RT-qPCR was performed on five selected genes (Table 3)
found to be differentially upregulated. The DNAse-
treated total RNA, identical to the RNA used in micro-
array sample preparation, was used as template for each
of the above 12 growth conditions, measured in tripli-
cates. Experiments were conducted with a QRT-PCR
thermal cycler (I-cycler; Bio-Rad, Hercules, CA) in com-
bination with the iScript One-Step RT-PCR Kit with
SYBR Green (Biorad).
Figure 9 Genomic content and organization of XOS utilization gene clusters identified within bifidobacteria. All strains were ordered top
down by highest sequence similarity of the XOS-binding proteins to the XOS-binding protein of B. lactis Bl-04 (balac_0514). Gene functions are
colored as: Glycoside hydrolases (red), XOS ABC transporters (green), xylose ABC transporters (light green), transcriptional regulators (light grey),
and putative XOS esterases, xylose isomerases (xyl.iso), xylulose kinases (xul.kin), alcohol dehydrogenases (Reductase) and a putative secreted
amidase (lysM) (all dark gray). All GH43 enzymes were annotated and differentiated by protein similarity to previously characterized xylosidases
(xyln) or arabinofuranosidases (arab) together with the GH8 and GH120 enzymes [37,38]. An insertion in B. longum JDM301 is shown by below
the gene cluster with an arrow indicating the position of the insert.
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Construction of phylogenetic tree of carbohydrate SBPs
The sequence dataset was compiled from oligosacchar-
ide-binding proteins all identified from previous works
or from the current study (Table 4). Sequence homologs
for each protein entry were identified by BLAST [66]
and restricted to either 100 hits or an e-value of 10-3
against the non-redundant database. All redundant se-
quences were removed and the remaining sequences to-
gether with a monosaccharide (fructose) binding
proteins were aligned with ClustalX [67] using the
Blosum series substitution matrix and a gap opening
penalty of 2, compared to the standard penalty of 10.
The resulting phylogenetic tree file was visualized
using Dendroscope [68]. Bootstrap values were
calculated by ClustalX using standard conditions
(1000 iterations).
Microarray submission
All raw data have been deposited in the GEO database
(Accession number: GSE41906) and complies with the
MIAME guidelines.
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Table 4 Identified clusters of oligosaccharide-binding proteins from Figure 8
Cluster Sub-cluster Substrate specificity Identified Organism Reference
Malto-oligosaccharides 1 α-(1,4)-gluco-oligosaccharides Listeria monocytogenes [72]
Streptococcus pneumoniae [73]
2 β-Cyclodextrin and maltose Bacillus subtilis [74]
3 Maltose L. casei BL23 [42]
4 Putative maltose B. animalis subsp lactis Bl-04 This study
5 Maltose B. longum NCC2705 [35]
Maltotriose B. lactis Bl-04 This study
β-glucosides - β-(1,4)-gluco-oligosaccharides B. breve UCC2003 [59]
β-galactosides A Lactose and B. longum NCC2705 [35] and
β-galacto-oligosaccharides B. lactis Bl-04 This study
B Lacto-N-biose B. bifidum [75]
B. longum [76]
XOS - β-(1,4)-xylo-oligosaccharides B. lactis Bl-04 This study
RFO A Raffinose and isomaltose Streptococcus mutans [43]
B Raffinose B. longum NCC2705 [35]
Raffinose and Isomaltose1 B. lactis Bl-04 This study
Root - Fructose B. longum NCC2705 [69]
Clusters are shown by numbers and if possible sub-clusters are listed with letters. The experimentally identified oligosaccharide-binding proteins used to generate
the tree are listed in the corresponding cluster and sub-cluster if possible.
1Including melibiose, panose and stachyose.
Table 5 Primer pairs used for RT-qPCR
ORF Primer 5' – 3' Product size (bp)
0054 CACACTCGCTCGAGATTC 140
AGGCCAATCATGCATACG
0475 GCTGACGATGGGAATGAC 160
GCTCGACGTGTTCTACTC
0483 CGTCGGAGTTCTTGATGG 142
CAGGCAGCCTATGACTTC
0514 GGCTGACCTTGGATTCTT 145
CTTCTCGCCCATGTAGTTG
1565 GAACGCCGTAGATCTTGC 148
ATGTTCGCCAATGACCAG
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